146 related articles for article (PubMed ID: 20509157)
1. ADAM12 is an effective marker in the second trimester of pregnancy for prenatal screening of Down syndrome.
Wang M; Lu S; Zhu Y; Li H
Prenat Diagn; 2010 Jun; 30(6):561-4. PubMed ID: 20509157
[TBL] [Abstract][Full Text] [Related]
2. Second trimester maternal serum ADAM12 levels in Down's syndrome pregnancies.
Donalson K; Turner S; Wastell H; Cuckle H
Prenat Diagn; 2008 Oct; 28(10):904-7. PubMed ID: 18785180
[TBL] [Abstract][Full Text] [Related]
3. [Second trimester screening for trisomy 21 using ADAM12-S as a maternal serum marker].
Jiang T; Lv L; Yang B; Sun YJ; Zhang XJ; Sun Y; Xu QJ; Xu ZF
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Jun; 29(3):314-8. PubMed ID: 22678798
[TBL] [Abstract][Full Text] [Related]
4. ADAM 12 as a second-trimester maternal serum marker in screening for Down syndrome.
Christiansen M; Spencer K; Laigaard J; Cowans NJ; Larsen SO; Wewer UM
Prenat Diagn; 2007 Jul; 27(7):611-5. PubMed ID: 17465398
[TBL] [Abstract][Full Text] [Related]
5. ADAM12 as a marker of trisomy 18 in the first and second trimester of pregnancy.
Spencer K; Cowans NJ
J Matern Fetal Neonatal Med; 2007 Sep; 20(9):645-50. PubMed ID: 17701664
[TBL] [Abstract][Full Text] [Related]
6. ADAM 12 may be used to reduce the false positive rate of first trimester combined screening for Down syndrome.
Christiansen M; Pihl K; Hedley PL; Gjerris AC; Lind PØ; Larsen SO; Krebs L; Larsen T
Prenat Diagn; 2010 Feb; 30(2):110-4. PubMed ID: 20013872
[TBL] [Abstract][Full Text] [Related]
7. ADAM 12 as a first-trimester maternal serum marker in screening for Down syndrome.
Laigaard J; Spencer K; Christiansen M; Cowans NJ; Larsen SO; Pedersen BN; Wewer UM
Prenat Diagn; 2006 Oct; 26(10):973-9. PubMed ID: 16892462
[TBL] [Abstract][Full Text] [Related]
8. The value of early second trimester PAPP-A and ADAM12 in screening for pre-eclampsia.
Bestwick JP; George LM; Wu T; Morris JK; Wald NJ
J Med Screen; 2012 Mar; 19(1):51-4. PubMed ID: 22357350
[TBL] [Abstract][Full Text] [Related]
9. Maternal serum ADAM12 levels correlate with PAPP-A levels during the first trimester.
Valinen Y; Peuhkurinen S; Järvelä IY; Laitinen P; Ryynanen M
Gynecol Obstet Invest; 2010; 70(1):60-3. PubMed ID: 20197665
[TBL] [Abstract][Full Text] [Related]
10. First trimester screening for trisomy 21 in gestational week 8-10 by ADAM12-S as a maternal serum marker.
Tørring N; Ball S; Wright D; Sarkissian G; Guitton M; Darbouret B
Reprod Biol Endocrinol; 2010 Oct; 8():129. PubMed ID: 21034452
[TBL] [Abstract][Full Text] [Related]
11. Effect of a new marker, ADAM12, on Down risk figures in first trimester screening.
Valinen Y; Laitinen P; Ranta J; Ignatius J; Jarvela I; Ryynänen M
J Matern Fetal Neonatal Med; 2009 Jul; 22(7):602-7. PubMed ID: 19736612
[TBL] [Abstract][Full Text] [Related]
12. Maternal serum ADAM12 (A disintegrin and metalloprotease) in chromosomally abnormal pregnancy at 11-13 weeks.
Poon LC; Chelemen T; Minekawa R; Frisova V; Nicolaides KH
Am J Obstet Gynecol; 2009 May; 200(5):508.e1-6. PubMed ID: 19285649
[TBL] [Abstract][Full Text] [Related]
13. Maternal smoking: age distribution, levels of alpha-fetoprotein and human chorionic gonadotrophin, and effect on detection of Down syndrome pregnancies in second-trimester screening.
Crossley JA; Aitken DA; Waugh SM; Kelly T; Connor JM
Prenat Diagn; 2002 Mar; 22(3):247-55. PubMed ID: 11920904
[TBL] [Abstract][Full Text] [Related]
14. Modeling Down syndrome screening performance using first-trimester serum markers.
Koster MP; Wortelboer EJ; Stoutenbeek P; Visser GH; Schielen PC
Ultrasound Obstet Gynecol; 2011 Aug; 38(2):134-9. PubMed ID: 21800388
[TBL] [Abstract][Full Text] [Related]
15. First trimester maternal serum PAPP-A, beta-hCG and ADAM12 in prediction of small-for-gestational-age fetuses.
Pihl K; Larsen T; Krebs L; Christiansen M
Prenat Diagn; 2008 Dec; 28(12):1131-5. PubMed ID: 19003798
[TBL] [Abstract][Full Text] [Related]
16. Detection of maternal serum hCG glycoform variants in the second trimester of pregnancies affected by Down syndrome using a lectin immunoassay.
Talbot JA; Spencer K; Abushoufa RA
Prenat Diagn; 2003 Jan; 23(1):1-5. PubMed ID: 12533803
[TBL] [Abstract][Full Text] [Related]
17. Distributions of current and new first-trimester Down syndrome screening markers in twin pregnancies.
Koster MP; Wortelboer EJ; Stoutenbeek P; Visser GH; Schielen PC
Prenat Diagn; 2010 May; 30(5):413-7. PubMed ID: 20306463
[TBL] [Abstract][Full Text] [Related]
18. Maternal serum ADAM12 in Chinese women undergoing screening for aneuploidy in the first trimester.
Liao C; Han J; Sahota D; Li DZ; Sun Q; Lin L; Zhou JY; Yang X; Pan M; Huang YN
J Matern Fetal Neonatal Med; 2010 Nov; 23(11):1305-9. PubMed ID: 20230315
[TBL] [Abstract][Full Text] [Related]
19. ADAM12: a novel first-trimester maternal serum marker for Down syndrome.
Laigaard J; Sørensen T; Fröhlich C; Pedersen BN; Christiansen M; Schiøtt K; Uldbjerg N; Albrechtsen R; Clausen HV; Ottesen B; Wewer UM
Prenat Diagn; 2003 Dec; 23(13):1086-91. PubMed ID: 14691998
[TBL] [Abstract][Full Text] [Related]
20. ADAM12s as a first-trimester screening marker of trisomy.
Wortelboer EJ; Linskens IH; Koster MP; Stoutenbeek P; Cuckle H; Blankenstein MA; Visser GH; van Vugt JM; Schielen PC
Prenat Diagn; 2009 Sep; 29(9):866-9. PubMed ID: 19544290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
